Home > Financial Ratios > ANUH PHARMA

ANUH PHARMA
Core EBITDA Growth

    Back to All Ratios
ANUH PHARMA is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for ANUH PHARMA
Please provide your vote to see the results

ANUH PHARMA Last 5 Year Core EBITDA Growth History

[Standalone]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Growth(%) 51.689.98-5.38102.79-20.82

What is the latest Core EBITDA Growth ratio of ANUH PHARMA ?

The latest Core EBITDA Growth ratio of ANUH PHARMA is 51.68 based on Mar2024 Standalone results.
Year Core EBITDA Growth
Mar202451.68
Mar20239.98
Mar2022-5.38
Mar2021102.79
Mar2020-20.82

How is Core EBITDA Growth of ANUH PHARMA Trending?

Years Core EBITDA Growth % Change
Mar2024 51.68
417.84
Mar2023 9.98
Positive
Mar2022 -5.38
Negative
Mar2021 102.79
Positive
Mar2020 -20.82 -

Other Financial Ratios of ANUH PHARMA


Compare Core EBITDA Growth ratio of peers of ANUH PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
ANUH PHARMA ₹1,079.9 Cr -6.5% 7.7% 46.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹441,838.0 Cr 1% 4.6% 47.5% Stock Analytics
DIVIS LABORATORIES ₹156,107.0 Cr 1% -3.2% 59.3% Stock Analytics
CIPLA ₹120,270.0 Cr -1.1% -0.3% 20.7% Stock Analytics
DR REDDYS LABORATORIES ₹113,077.0 Cr 2.2% 12.1% 21.6% Stock Analytics
ZYDUS LIFESCIENCES ₹96,553.2 Cr -2.7% 0.8% 43.8% Stock Analytics


ANUH PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
ANUH PHARMA

-6.5%

7.7%

46.9%

SENSEX

-2.1%

-2%

11.3%


You may also like the below Video Courses